In the past two weeks, PB Fintech has slipped 28% after Yashish Dahiya, executive director and CEO, and Alok Bansal, whole time director and CFO, sold 6.09 million shares of the company
A combined 74.4 million equity shares had changed hands on the bourses till 9:52 AM. According to reports, British telecom giant Vodafone was in discussions to sell around 5% stake in Indus Towers
The stock of the pharmaceutical company, which has a significant presence in the Russian market, has fallen below its previous low of Rs 4,135.90 touched on March 19, 2021
Insurance related stocks could see some action as the India Protection Quotient (IPQ) survey 4, stated that term insurance ownership has gone up from 36 per cent to 43 per cent in the last two years.
The good growth in infrastructure, core sector as well as automobile and real estate is likely to have a positive effect on the overall demand of paint for the industry in the long run.
On Tuesday, Baillie Gifford Pacific Fund A Sub Fund Of Baillie Gifford Overseas Growth Funds ICVC has sold 9.43 million shares or 1.55% stake in Dhani Services at price of Rs 85.07 on the NSE
Going forward, with introduction of new products, expansion of distribution network and capacity enhancement, the management foresees strong growth in overall revenues
The company said the general cost inflation affecting the business - especially raw materials, energy and logistic costs.
Shares of Crompton Greaves Consumer Electricals also rallied 5 per cent to Rs 396.35 on the BSE in intra-day trade
The stock of the Adani Group edible oil major had closed at Rs 314.40 on Tuesday, correcting 25 per cent from its record high level of Rs 419.90 on February 11, 2022.
Stocks like Sun Pharma, Dr.Reddy's and others having exposure to Europe are likel to be in focus as the Russia-Ukraine crisis deepens.
The weakening in the asset quality was partly due to the bank's customer profile, mainly comprising small-ticket borrowers in the self-employed segment, that was more severely impacted by the pandemic
With the past two days decline, the stock has plunged 78 per cent from its 52-week high level of Rs 380 on March 2, 2021.
Infinity Holdings Group made an open offer to buy 26 per cent stake in the company at a price of Rs 235 per share
The company clarified that Enforcement Directorate (ED) investigation did not pertain to the company and has no bearing on the business and operations of the company.
Even if OMCs are not made to share any under-recovery, the continued pricing intervention would make it utterly difficult to divest government's stake in BPCL, Motilal Oswal said in its report
The stock hit a new low of Rs 1,218.80, down 8 per cent in the intra-day trade
Panacea Biotec may see some action on plans to launch a comprehensive coronavirus vaccine in association with THSTI.
Analysts anticipate a faster recovery in the demand environment and are hopeful that consumption will reach normalised pre-Covid levels in H1FY23
The stock has fallen 12 per cent from its listing day high of Rs 993 on February 16, 2022. Currently, it is trading just 1 per cent higher over its issue price of Rs 866 per share.